HUMP: Mesh Versus Suture Repair for Umbilical Hernias

Sponsor
Ruth Kaufmann, MD (Other)
Overall Status
Completed
CT.gov ID
NCT00789230
Collaborator
(none)
300
12
2
115
25
0.2

Study Details

Study Description

Brief Summary

The purpose of the present study is to investigate whether or not the use of mesh is indicated in the repair of all size umbilical hernias as to reduce the rate of recurrence. This method is regularly used in umbilical hernia reconstruction although most surgeons repair small hernias using suture repair (fascia adaptation). Especially risk factors for hernia recurrence such as hernia size and BMI > 30 kg/m2 need to be evaluated and correlated to the method of hernia repair.

Condition or Disease Intervention/Treatment Phase
  • Procedure: primary suture closure
  • Device: mesh enforced closure
N/A

Detailed Description

Purpose The purpose of the present study is to investigate whether or not the use of mesh is indicated in the repair of all size umbilical hernias as to reduce the rate of recurrence. This method is regularly used in umbilical hernia reconstruction although most surgeons repair small hernias using suture repair (fascia adaptation). Especially risk factors for hernia recurrence such as hernia size and BMI > 30 kg/m2 need to be evaluated and correlated to the method of hernia repair.

Study design Randomised controlled, double blinded, multi-centre trial. 300 consecutive patients with an umbilical hernia will be included in the study. Patients will be randomised in one of two groups of 150 patients each. Group 1 will include patients that will undergo primary (suture) repair; group 2 umbilical hernias will be repaired using a pre-peritoneal, flat polypropylene mesh in a tension free fashion.

Stratification will be utilized for the size of the hernia (1-2 cm or ≥2-4 cm) and the participating centre. Patients will visit the outpatient clinic after 2-3 weeks and after 3, 12 and 24 months.

The cumulative hernia recurrence rate during the 2-years follow-up period will be the primary outcome of the study. Complications, pain and QOL are secondary endpoints.

Statistical analysis All analyses will be performed according to the intention to treat principle and as specified in the protocol.

Financial support None.

Study Design

Study Type:
Interventional
Actual Enrollment :
300 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Suture versus mesh repair in umbilical hernia patientsSuture versus mesh repair in umbilical hernia patients
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Mesh Versus Suture Repair for Umbilical Hernias: a Double Blinded, Randomised Controlled Clinical Trial
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Apr 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: primary suture

Procedure: primary suture closure
primary suture closure of hernia

Active Comparator: mesh enforced closure

Device: mesh enforced closure
mesh enforced closure of hernia

Outcome Measures

Primary Outcome Measures

  1. hernia recurrence rate [24 months]

Secondary Outcome Measures

  1. Post-operative morbidity and complications [3 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Primary umbilical hernia

  • Signed Informed consent

Exclusion Criteria:
  • Umbilical hernia ≥ 4 cm diameter

  • Recurrence

  • Midline laparotomy

  • Ascites/Cirrhosis

  • ASA score IV or above

  • Incarcerated hernia/emergency procedures

Contacts and Locations

Locations

Site City State Country Postal Code
1 Studienzentrum der Deutschen Gesellschaft für Chirurgie Heidelberg Germany
2 University of Witten/Herdecke Witten Germany
3 Multimedica Milano Italy
4 Erasmus University Medical Center Rotterdam Zuid Holland Netherlands 3015CN
5 Onze Lieve Vrouwe Gasthuis Amsterdam Netherlands
6 Wilhelmina Ziekenhuis Assen Netherlands
7 Reinier de Graaf Gasthuis Delft Netherlands
8 Havenziekenhuis Rotterdam Netherlands
9 Ikazia Rotterdam Netherlands
10 Maasstad Ziekenhuis Rotterdam Netherlands
11 Máxima Medisch Centrum Veldhoven Netherlands
12 Isala Zwolle Netherlands

Sponsors and Collaborators

  • Ruth Kaufmann, MD

Investigators

  • Principal Investigator: J. Jeekel, MD, PhD, Erasmus Medical Center
  • Principal Investigator: J.F. Lange, MD, PhD, Erasmus Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ruth Kaufmann, MD, R. Kaufmann, Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT00789230
Other Study ID Numbers:
  • HUMP
First Posted:
Nov 11, 2008
Last Update Posted:
Feb 26, 2018
Last Verified:
Feb 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ruth Kaufmann, MD, R. Kaufmann, Erasmus Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 26, 2018